Shares of Xunce Technology (03317) have surged more than 26%, with a gain of 21.65% at the time of writing to reach HK$125.3, generating a turnover of HK$325 million.

The significant movement follows recent corporate developments. On the evening of June 26th, the company announced that its 2025 Annual General Meeting was held, during which all 12 ordinary and special resolutions were reviewed and approved.

A key resolution that garnered market attention was the "Proposal to Grant the Board a General Mandate for Share Repurchases." This authorization empowers the board to repurchase, at an appropriate time, up to 10% of the total issued H shares of the company as of the date the resolution was passed.

Based on the total of 267,175,506 issued H shares as of the latest practicable date, this mandate allows for the repurchase of a maximum of approximately 26.718 million H shares.

Analyst Sentiment and Company Strengths

It is also noteworthy that since June 2026, Xunce Technology has received a series of positive assessments from several major securities firms, including Haitong International, CITIC Securities, Huatai Securities, and China Securities.

Analysis from China Securities highlights that Xunce has established three core competitive advantages: its capability for millisecond-level, end-to-end real-time data processing; over a decade of deep industry experience in high-barrier sectors, creating unique and hard-to-replicate expertise; and a customer retention rate exceeding 90%, driven by products that are deeply integrated into client workflows.

Huatai Securities pointed out that the company's TokenOS platform covers the entire data pipeline from cleansing and modeling to real-time computation and model adaptation. It outputs standardized Tokens that can directly inform business decisions and is well-suited for high-value sectors such as healthcare, energy, and advanced manufacturing.